PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis • Value Chain Analysis PART 04: MARKET SIZING • Market definition • Market sizing 2019 • Market size and forecast 2019-2024 • Market Outlook PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: CUSTOMER LANDSCAPE PART 07: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Breast implants - Market size and forecast 2019-2024 • Tissue expanders - Market size and forecast 2019-2024 • Market opportunity by product PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2019-2024 • Europe - Market size and forecast 2019-2024 • Asia - Market size and forecast 2019-2024 • ROW - Market size and forecast 2019-2024 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Strong research funding • Increasing number of awareness campaigns • Growing popularity of DBT PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Allergan Plc • CEREPLAS • Establishment Labs Holdings Inc. • GC Aesthetics Inc. • Groupe SEBBIN SAS • Ideal Implant Inc. • Johnson & Johnson • Laboratories Arion • POLYTECH Health & Aesthetics GmbH • Sientra Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global healthcare supplies market Exhibit 02: Segments of global healthcare supplies market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Vendors: Key offerings Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2019 Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions) Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) Exhibit 10: Five forces analysis 2019 Exhibit 11: Five forces analysis 2024 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2019 Exhibit 18: Customer landscape Exhibit 19: Product - Market share 2019-2024 (%) Exhibit 20: Comparison by product Exhibit 21: Breast implants - Market size and forecast 2019-2024 ($ millions) Exhibit 22: Breast implants - Year-over-year growth 2020-2024 (%) Exhibit 23: Tissue expanders - Market size and forecast 2019-2024 ($ millions) Exhibit 24: Tissue expanders - Year-over-year growth 2020-2024 (%) Exhibit 25: Market opportunity by product Exhibit 26: Market share by geography 2019-2024 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions) Exhibit 29: North America - Year-over-year growth 2020-2024 (%) Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions) Exhibit 31: Europe - Year-over-year growth 2020-2024 (%) Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions) Exhibit 33: Asia - Year-over-year growth 2020-2024 (%) Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions) Exhibit 35: ROW - Year-over-year growth 2020-2024 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Estimated breast cancer rates in 2018 Exhibit 39: Cosmetic surgical procedures Exhibit 40: Impact of drivers and challenges Exhibit 41: Organizations conducting awareness campaigns Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Allergan Plc - Vendor overview Exhibit 48: Allergan Plc - Business segments Exhibit 49: Allergan Plc - Organizational developments Exhibit 50: Allergan Plc - Segment focus Exhibit 51: Allergan Plc - Key offerings Exhibit 52: CEREPLAS - Vendor overview Exhibit 53: CEREPLAS - Product segments Exhibit 54: CEREPLAS - Key offerings Exhibit 55: Establishment Labs Holdings Inc. - Vendor overview Exhibit 56: Establishment Labs Holdings Inc. - Business segments Exhibit 57: Establishment Labs Holdings Inc. - Organizational developments Exhibit 58: Establishment Labs Holdings Inc. - Key offerings Exhibit 59: GC Aesthetics Inc. - Vendor overview Exhibit 60: GC Aesthetics Inc. - Product segments Exhibit 61: GC Aesthetics Inc. - Organizational developments Exhibit 62: GC Aesthetics Inc. - Key offerings Exhibit 63: Groupe SEBBIN SAS - Vendor overview Exhibit 64: Groupe SEBBIN SAS - Product segments Exhibit 65: Groupe SEBBIN SAS - Key offerings Exhibit 66: Ideal Implant Inc. - Vendor overview Exhibit 67: Ideal Implant Inc. - Key offerings Exhibit 68: Johnson & Johnson - Vendor overview Exhibit 69: Johnson & Johnson - Business segments Exhibit 70: Johnson & Johnson - Organizational developments Exhibit 71: Johnson & Johnson - Geographic focus Exhibit 72: Johnson & Johnson - Segment focus Exhibit 73: Johnson & Johnson - Key offerings Exhibit 74: Laboratories Arion - Vendor overview Exhibit 75: Laboratories Arion - Key offerings Exhibit 76: POLYTECH Health & Aesthetics GmbH - Vendor overview Exhibit 77: POLYTECH Health & Aesthetics GmbH - Product segments Exhibit 78: POLYTECH Health & Aesthetics GmbH - Key offerings Exhibit 79: Sientra Inc. - Vendor overview Exhibit 80: Sientra Inc. - Business segments Exhibit 81: Sientra Inc. - Organizational developments Exhibit 82: Sientra Inc. - Geographic focus Exhibit 83: Sientra Inc. - Segment focus Exhibit 84: Sientra Inc. - Key offerings Exhibit 85: Validation techniques employed for market sizing Exhibit 86: Definition of market positioning of vendors

Allergan Plc, CEREPLAS, Establishment Labs Holdings Inc., GC Aesthetics Inc., Groupe SEBBIN SAS, Ideal Implant Inc., Johnson & Johnson, Laboratories Arion, POLYTECH Health & Aesthetics GmbH, and Sientra Inc.